Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02.

Sandra Schmitz,M-C. Kaminsky-Forrett,Stéphanie Henry,Sylvie Zanetta,Lionnel Geoffrois,Emmanuelle Bompas,Anne Moxhon,J. Guigay,J. H. Machiels

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02.

2010

Sandra Schmitz
M-C. Kaminsky-Forrett
Stéphanie Henry
Sylvie Zanetta
Lionnel Geoffrois
Emmanuelle Bompas
Anne Moxhon
J. Guigay
J. H. Machiels

5500 Background: Insulin-like growth factor-1 receptor (IGF-1R) plays an important role in the growth and apoptosis of cancer cells, and is overexpressed in squamous cell carcinoma of the head and ...

Keywords:

Carcinoma
Figitumumab
Pathology
Cancer research
Oncology
Medicine
Internal medicine
in patient
Cancer cell
Apoptosis
head and neck
Phases of clinical research
basal cell
Receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations